Alamar Biosciences, Inc.
Alamar Biosciences, Inc.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Alamar Biosciences, Inc.(Alamar Biosciences, Inc.) IPO는 언제 예정인가요?
Alamar Biosciences, Inc.(Alamar Biosciences, Inc.)는 이미 상장이 완료되었습니다. 상장일은 2026년 4월 17일입니다.
Alamar Biosciences, Inc.(Alamar Biosciences, Inc.)의 기업가치(밸류에이션)는 얼마인가요?
Alamar Biosciences, Inc.(Alamar Biosciences, Inc.)의 현재 추정 기업가치는 약 $191M입니다. Life Sciences Tools & Services 섹터에 속하며, 실제 IPO 시점의 공모가와 시장 수요에 따라 최종 밸류에이션은 달라질 수 있습니다.
Alamar Biosciences, Inc.(Alamar Biosciences, Inc.) IPO에 개인투자자도 참여할 수 있나요?
미국 시장 IPO의 경우, 일반적으로 기관투자자에 먼저 배정되며 개인투자자의 직접 공모 참여는 제한적입니다. 상장 이후 NASDAQ Global Select에서 주식을 매수할 수 있으며, 일부 증권사에서는 IPO 주식 사전 신청 서비스를 제공합니다.
Alamar Biosciences, Inc.(Alamar Biosciences, Inc.)는 어떤 회사인가요?
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.